All Stories

  1. Investigating a new C2-symmetric testosterone dimer and its dihydrotestosterone analog: Synthesis, antiproliferative activity on prostate cancer cell lines and interaction with CYP3A4
  2. Synthesis of new para-aminobenzoic acid derivatives, in vitro biological evaluation and preclinical validation of DAB-2-28 as a therapeutic option for the treatment of bladder cancer
  3. Structural Characterization of Cis– and Trans–Pt(NH3)2Cl2 Conjugations with Chitosan Nanoparticles
  4. Design of novel 4-maleimidylphenyl-hydrazide molecules displaying anti-inflammatory properties: Refining the chemical structure
  5. Innovative C-symmetric testosterone and androstenedione dimers: Design, synthesis, biological evaluation on prostate cancer cell lines and binding study to recombinant CYP3A4
  6. Recent Advances in the Use of the Dimerization Strategy as a Means to Increase the Biological Potential of Natural or Synthetic Molecules
  7. Locating the binding sites of two aminobenzoic acid derivatives on tRNA: drug binding efficacy and RNA structure
  8. Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways
  9. Binding efficacy of aminobenzoic acid derivatives with DNA duplex: drug binding sites and DNA structure and dynamics
  10. Biomolecular study and conjugation of two para-aminobenzoic acid derivatives with serum proteins: drug binding efficacy and protein structural analysis
  11. Second-generation testosterone-platinum(II) hybrids for site-specific treatment of androgen receptor positive prostate cancer: Design, synthesis and antiproliferative activity
  12. Complexation of cis-Pt and trans-Pt(NH3)2Cl2 with serum proteins: A potential application for drug delivery
  13. How to utilize academic research efforts in cancer drug discovery
  14. Cloning and characterization of norbelladine synthase catalyzing the first committed reaction in Amaryllidaceae alkaloid biosynthesis
  15. Testo and testo-Pt(II) bind DNA at different locations
  16. Location of multiple binding sites for testo and testo–Pt(II) with tRNA
  17. Conjugation of testo and testo-Pt(II) with serum proteins: Loading efficacy and protein conformation
  18. PAMAM dendrimers in drug delivery: loading efficacy and polymer morphology
  19. Effect of testosterone and its aliphatic and aromatic dimers on DNA morphology
  20. Testosterone and its dimers alter tRNA morphology
  21. Synthesis of novel C2-symmetric testosterone dimers and evaluation of antiproliferative activity on androgen-dependent and -independent prostate cancer cell lines
  22. Review on the delivery of steroids by carrier proteins
  23. An overview on the delivery of antitumor drug doxorubicin by carrier proteins
  24. Review on the binding of anticancer drug doxorubicin with DNA and tRNA: Structural models and antitumor activity
  25. The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4
  26. An overview of molecular hybrids in drug discovery
  27. Transporting testosterone and its dimers by serum proteins
  28. Exploring the Synthesis and Anticancer Potential of L-Tyrosine-Platinum(II) Hybrid Molecules
  29. New Testosterone Derivatives as Semi-Synthetic Anticancer Agents Against Prostate Cancer: Synthesis and Preliminary Biological Evaluation
  30. Encapsulation of testosterone and its aliphatic and aromatic dimers by milk beta-lactoglobulin
  31. Identification of an anti-inflammatory derivative with anti-cancer potential: The impact of each of its structural components on inflammatory responses in macrophages and bladder cancer cells
  32. Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: Structural features and biological implications
  33. New platinum(II) complexes conjugated at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: Design, synthesis, structure–activity relationships and biological evaluation
  34. Steroid-linked nitrogen mustards as potential anticancer therapeutics: A review
  35. tRNA Binding to Antitumor Drug Doxorubicin and Its Analogue
  36. ERα-Targeted Therapy in Ovarian Cancer Cells by a Novel Estradiol-Platinum(II) Hybrid
  37. Synthesis and preliminary in vitro biological evaluation of 7α-testosterone–chlorambucil hybrid designed for the treatment of prostate cancer
  38. Advances in the development of hybrid anticancer drugs
  39. Antibiotic doxorubicin and its derivative bind milk β-lactoglobulin
  40. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer
  41. Probing the Binding Sites of Antibiotic Drugs Doxorubicin and N-(trifluoroacetyl) Doxorubicin with Human and Bovine Serum Albumins
  42. Design of novel tyrosine-nitrogen mustard hybrid molecules active against uterine, ovarian and breast cancer cell lines
  43. Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues
  44. SAR study of tyrosine–chlorambucil hybrid regioisomers; synthesis and biological evaluation against breast cancer cell lines
  45. Design, synthesis and biological evaluation of estradiol-PEG-linked platinum(II) hybrid molecules: Comparative molecular modeling study of three distinct families of hybrids
  46. Synthesis of d- and l-tyrosine-chlorambucil analogs active against breast cancer cell lines
  47. Evaluation of in vivo biological activities of tetrapyrrole ethanolamides as novel anticancer agents
  48. First synthesis of separable isomeric testosterone dimers showing differential activities on prostate cancer cells
  49. Design, synthesis and biological evaluation of estradiol–chlorambucil hybrids as anticancer agents
  50. VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo
  51. Functionalization of Testosterone at Position 7α and Synthesis of 7α-(3-Methoxypropyl)-4-androsten-17β-ol-3-one
  52. Pure N-Alkylaminopropionic Acid and N-Alkylaminodipropionic Acid Sodium Salts: Synthesis, Characterization, and Physicochemical Properties
  53. Errata
  54. Simple and Efficient Synthesis of Steroidal Hybrids of Estrogen and Vitamin D3
  55. Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta
  56. Synthesis and cytotoxic activity of benzopyran-based platinum(II) complexes
  57. Transfer RNA Bindings to Antitumor Estradiol-Platinum(II) Hybrid and Cisplatin
  58. A novel series of potent cytotoxic agents targeting G2/M phase of the cell cycle and demonstrating cell killing by apoptosis in human breast cancer cells
  59. Synthesis and Preliminary Biological Evaluation of Estrone Dimers
  60. Synthesis of Substituted Triarylpyran through an Unexpected Intramolecular Cyclization
  61. Natural and Synthetic Biologically Active Dimeric Molecules: Anticancer Agents, Anti-HIV Agents, Steroid Derivatives and Opioid Antagonists
  62. Synthesis of 17β-estradiol-linked platinum(II) complexes and their cytocidal activity on estrogen-dependent and -independent breast tumor cells
  63. A facile synthesis of C2-symmetric 17β-estradiol dimers
  64. Synthesis and Preliminary in Vitro Cytotoxic Activity of New Triphenylethylene Dimers
  65. Ionic Characterization of a Synthetic Amphoteric Surfactant:  N,N-((Butyloxy)propyl)amino Diacetic Acid
  66. The synthesis and characterization of new triphenylethylene platinum(II) complexes
  67. Conjugation of doxorubicin to monoclonal anti-carcinoembryonic antigen antibody via novel thiol-directed cross-linking reagents
  68. Synthesis and in vitro biological evaluation of new triphenylethylene platinum (II) complexes
  69. The synthesis of new platinum(II) complexes linked to non-steroidal estrogens
  70. Synthesis of New N-(Trifluoroacetyl) Doxorubicin Analogues
  71. A stereocontrolled intramolecular cycloaddition – sigmatropic rearrangement approach to a tricyclo[7.4.01,6.01,10]tridecane precursor for (±) gascardic acid
  72. Synthesis and transannular Diels–Alder reaction of a 13-membered macrocyclic triene having a tetrasubstituted enol ether as dienophile
  73. An intramolecular cycloaddition-sigmatropic rearrangement approach to (±) gascardic acid
  74. Intramolecular Diels–Alder reactions of cyclopentadiene systems: Model studies for the total synthesis of the capnellenes
  75. Synthesis and transannular diels-alder reaction of a 13-membered macrocyclic triene having a tetrasubstituted enol ether as a dienophile
  76. 1,5-Acyclic stereoselection. The stereocontrolled synthesis of optically active vitamin E fourteen-carbon side chain alcohol
  77. Asymmetric induction on the Schiff bases